CAR T-CELL THERAPY

Latest News

Leveraging ctDNA to Predict Response in Patients With Myeloma Receiving CAR T Cells
Leveraging ctDNA to Predict Response in Patients With Myeloma Receiving CAR T Cells

March 20th 2023

In an interview with Targeted Oncology, Hitomi Hosoya, MD, discussed the potential use of ctDNA in the myeloma space, including its ability to sequence BCMA-targeted therapies and reduce the need for bone marrow exams.

CAR T-Cell Therapy With CYAD-01 Shows Efficacy in Myeloid Malignancies
CAR T-Cell Therapy With CYAD-01 Shows Efficacy in Myeloid Malignancies

March 13th 2023

Brexu-cel Generates Durable Responses and Survival Benefits in R/R B-ALL
Brexu-cel Generates Durable Responses and Survival Benefits in R/R B-ALL

February 22nd 2023

CD22-Directed CAR T-cell Therapy Overcomes CD19 Relapse in LBCL With High CR Rates
CD22-Directed CAR T-cell Therapy Overcomes CD19 Relapse in LBCL With High CR Rates

February 17th 2023

GPRC5D-Targeted CAR T-Cells Show Efficacy in Phase 1 R/R MM Trial
GPRC5D-Targeted CAR T-Cells Show Efficacy in Phase 1 R/R MM Trial

February 2nd 2023

Video Series
Video Interviews

More News